Moderna said on Wednesday that it had started a mid-stage study, testing a booster dose of its COVID vaccine specifically designed to target the Omicron variant, a day after rival Pfizer launched a similar trial.
Dr. Robert Malone on Bill Gates: monopolized the global response to infectious disease
Rumble
“He has systematically monopolized the global response to infectious disease”
